ENG/中
老虎證券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息（分红）
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登入
立即註冊
Toggle
港股
詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務
映恩生物-B
314.000
+9.000
2.95%
手動刷新
成交量：
1,281.90萬
成交額：
36.86億
市值：
276.43億
市盈率：
-2.19
高：
315.000
開：
272.000
低：
272.000
收：
305.000
52周最高：
563.500
52周最低：
165.500
股本：
8,803.63萬
香港流通股本：
8,803.63萬
量比：
23.70
換手率：
14.56%
股息：
- -
股息率：
- -
每股收益(LYR):
-143.160
淨資產收益率：
--
總資產收益率：
-6.51%
市淨率：
8.70
市盈率(LYR):
-2.19
市銷率:
11.68
資料載入中...
總覽
公司
新聞
公告
公司資料
公司名字：
映恩生物-B
交易所：
SEHK
成立時間：
2019
員工人數：
191
公司地址：
Full floor, 11th Floor,Tower A, Datang International Plaza,China Construction Engineering Group,No. 868 Yinghua Road, Pudong New Area,Shanghai,Shanghai Province,China
官網：
http://www.dualitybiologics.com
郵編：
- -
電話：
86 21 2601 8730
傳真：
- -
簡介：
映恩生物是一家主要從事臨床階段生物製藥的投資控股公司。該公司致力於為癌症和自身免疫性疾病等患者研發抗體偶聯藥物（ADC）創新藥物。該公司的主要候選藥物產品包括DB-1303/BNT323、DB-1311/BNT324、DB-1310、DB-1305/BNT325、DB-1419和DB-2304。該公司的產品主要用於靶向治療子宮內膜癌（EC）、乳腺癌（BC）、小細胞肺癌（SCLC）、去勢抵抗性前列腺癌（CRPC）、食管鱗狀細胞癌（ESCC）及頭頸部鱗狀細胞癌（HNSCC）。該公司主要在國內和國外市場開展業務。
董事
名稱
職位
朱忠遠
董事會主席，執行董事，提名委員會主席
張韶壬
執行董事
司文
執行董事，薪酬委員會委員
謝東
獨立非執行董事，提名委員會委員，審計委員會主席
高鳳勇
獨立非執行董事，薪酬委員會委員，審計委員會委員
揣姝茵
獨立非執行董事，薪酬委員會主席，提名委員會委員，審計委員會委員
蔡志洋
非執行董事
余濤
非執行董事
股東
名稱
職位
朱忠遠
首席執行官
花海清
高級副總裁，藥物發現負責人
於鑫
副總裁，監管事務負責人
曾穎雯
聯席公司秘書
袁佳麗
聯席公司秘書，法律及合規負責人
王昕
首席商務官
邱楊
首席科學官
張韶壬
財務副總裁
司文
人力資源執行總監
顧薇
首席醫學官
施榕
開發科學副總裁
儲瑞銀
轉化醫學副總裁
周嵐
商業戰略副總裁
牟驊
全球首席醫學官
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/09606/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"09606","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09606\",,,,,undefined,":{"symbol":"09606","market":"HK","secType":"STK","nameCN":"映恩生物-B","latestPrice":314,"timestamp":1760515692007,"preClose":305,"halted":0,"volume":12818956,"delay":0,"floatShares":88036299,"shares":88036299,"eps":-143.1595057740182,"marketStatus":"未開盤","change":9,"latestTime":"10-15 16:08:12","open":272,"high":315,"low":272,"amount":3685518692,"amplitude":0.140984,"askPrice":314.2,"askSize":100,"bidPrice":314,"bidSize":2400,"shortable":3,"etf":0,"ttmEps":-124.19343430921855,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1760578200000},"marketStatusCode":0,"adr":0,"listingDate":1744646400000,"exchange":"SEHK","adjPreClose":305,"openAndCloseTimeList":[[1760491800000,1760500800000],[1760504400000,1760515200000]],"volumeRatio":23.701841307282862,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09606\",,,,,undefined,":{"symbol":"09606","floatShares":88036299,"roa":"-6.51%","roe":"--","lyrEps":-143.159517,"volumeRatio":23.701841307282862,"shares":88036299,"dividePrice":0,"high":315,"amplitude":0.140984,"preClose":305,"low":272,"week52Low":165.5,"pbRate":"8.70","psRate":"11.68","week52High":563.5,"institutionHeld":0,"latestPrice":314,"committee":0.92,"eps":-143.1595057740182,"divideRate":0,"volume":12818956,"delay":0,"ttmEps":-124.19343430921855,"open":272,"prevYearClose":94.6,"prevWeekClose":294.8,"prevMonthClose":363.6,"prevQuarterClose":363.6,"fiveDayClose":323,"twentyDayClose":510,"sixtyDayClose":331.2},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/09606\",params:#limit:5,,,undefined,":[{"date":"2025-08-26","symbol":"09606","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756171800000,"name":null,"time":"","dateTimestamp":1756137600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"09606\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"09606\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.1667,"buy":0.8333,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.8333,"analysts":6,"updateTime":1759507200000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/09606\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"09606","date":"2025-10-14","current":-2.528314,"percent":0.983871,"low":-29.984477,"twenty":-25.184074,"median":-16.520891,"eighty":-11.537034,"high":-7.368305,"avg":-17.913398,"sd":6.082489,"marketCap":26851060520},"quantilePoints":[{"date":"2025-04-17","current":-14.905978,"twenty":-15.065639,"median":-14.442293,"eighty":-11.334487,"marketCap":16635152800},{"date":"2025-04-25","current":-15.846935,"twenty":-16.770434,"median":-15.576033,"eighty":-14.349556,"marketCap":17719522633},{"date":"2025-05-02","current":-16.438538,"twenty":-16.715855,"median":-16.124153,"eighty":-14.985809,"marketCap":18420101638},{"date":"2025-05-09","current":-15.074661,"twenty":-16.551291,"median":-15.826729,"eighty":-15.074661,"marketCap":17010399982},{"date":"2025-05-16","current":-15.043786,"twenty":-16.438538,"median":-15.220044,"eighty":-14.405796,"marketCap":17114249721},{"date":"2025-05-23","current":-16.495727,"twenty":-16.438538,"median":-15.262587,"eighty":-14.582474,"marketCap":18822153243},{"date":"2025-05-30","current":-16.208434,"twenty":-16.401371,"median":-15.460562,"eighty":-14.726132,"marketCap":18575651704},{"date":"2025-06-06","current":-16.427701,"twenty":-16.438538,"median":-15.666395,"eighty":-14.905978,"marketCap":18874975001},{"date":"2025-06-13","current":-20.940103,"twenty":-16.693343,"median":-15.893657,"eighty":-15.005253,"marketCap":24069114577},{"date":"2025-06-20","current":-18.479443,"twenty":-18.428819,"median":-16.104695,"eighty":-15.043786,"marketCap":21199132371},{"date":"2025-06-27","current":-18.0452,"twenty":-18.863356,"median":-16.282988,"eighty":-15.074661,"marketCap":20758951051},{"date":"2025-07-04","current":-21.227749,"twenty":-18.942282,"median":-16.427701,"eighty":-15.074735,"marketCap":24421259633},{"date":"2025-07-11","current":-22.045806,"twenty":-19.683704,"median":-16.508309,"eighty":-15.190609,"marketCap":25336836779},{"date":"2025-07-18","current":-25.758166,"twenty":-20.839221,"median":-16.693343,"eighty":-15.21995,"marketCap":29580184704},{"date":"2025-07-25","current":-25.970367,"twenty":-21.539184,"median":-16.981252,"eighty":-15.260218,"marketCap":29932329760},{"date":"2025-08-01","current":-24.963588,"twenty":-22.267132,"median":-18.096065,"eighty":-15.298157,"marketCap":28594178547},{"date":"2025-08-08","current":-27.998627,"twenty":-24.402884,"median":-18.454131,"eighty":-15.429476,"marketCap":32150843612},{"date":"2025-08-15","current":-27.487815,"twenty":-25.397092,"median":-18.863356,"eighty":-15.513126,"marketCap":31516982512},{"date":"2025-08-22","current":-26.341915,"twenty":-25.761111,"median":-19.052333,"eighty":-15.750472,"marketCap":30108402288},{"date":"2025-08-29","current":-8.977182,"twenty":-25.761111,"median":-19.118727,"eighty":-15.513126,"marketCap":27784244918},{"date":"2025-09-05","current":-10.341403,"twenty":-25.547361,"median":-18.897362,"eighty":-15.21995,"marketCap":31974771084},{"date":"2025-09-12","current":-12.806892,"twenty":-25.484142,"median":-18.479443,"eighty":-15.036079,"marketCap":39669140558},{"date":"2025-09-19","current":-11.291493,"twenty":-25.397092,"median":-18.151913,"eighty":-14.569138,"marketCap":34950396808},{"date":"2025-09-26","current":-9.575685,"twenty":-25.265241,"median":-17.183112,"eighty":-14.242848,"marketCap":29562577451},{"date":"2025-10-03","current":-9.769092,"twenty":-25.225948,"median":-16.756996,"eighty":-13.467837,"marketCap":30231653057},{"date":"2025-10-10","current":-8.39875,"twenty":-25.201143,"median":-16.551291,"eighty":-12.508489,"marketCap":25953090627},{"date":"2025-10-14","current":-8.708036,"twenty":-25.184074,"median":-16.520891,"eighty":-11.537034,"marketCap":26851060520}],"updateTime":1760566500362},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":1934829138,"yearFounded":2019,"employeeNum":191,"address":"Full floor, 11th Floor,Tower A, Datang International Plaza,China Construction Engineering Group,No. 868 Yinghua Road, Pudong New Area,Shanghai,Shanghai Province,China","officePhone":"86 21 2601 8730"},"stockCompanyDetail":{"websiteUrl":"http://www.dualitybiologics.com","stockEarnings":[{"period":"1week","weight":-0.0279},{"period":"1month","weight":-0.3843},{"period":"3month","weight":-0.0438},{"period":"6month","weight":0.57},{"period":"1year","weight":2.3192},{"period":"ytd","weight":2.3192}],"compareEarnings":[{"period":"1week","weight":-0.0342},{"period":"1month","weight":-0.0203},{"period":"3month","weight":0.0576},{"period":"6month","weight":0.2111},{"period":"1year","weight":0.2752},{"period":"ytd","weight":0.2917}],"compareStock":{"symbol":"HSI","name":"恆生指數"},"description":"映恩生物是一家主要從事臨床階段生物製藥的投資控股公司。該公司致力於為癌症和自身免疫性疾病等患者研發抗體偶聯藥物（ADC）創新藥物。該公司的主要候選藥物產品包括DB-1303/BNT323、DB-1311/BNT324、DB-1310、DB-1305/BNT325、DB-1419和DB-2304。該公司的產品主要用於靶向治療子宮內膜癌（EC）、乳腺癌（BC）、小細胞肺癌（SCLC）、去勢抵抗性前列腺癌（CRPC）、食管鱗狀細胞癌（ESCC）及頭頸部鱗狀細胞癌（HNSCC）。該公司主要在國內和國外市場開展業務。","exchange":"SEHK","name":"映恩生物-B","nameEN":"DUALITYBIO-B"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"09606\",market:\"HK\",,,undefined,":{"directors":[{"name":"朱忠遠","position":"董事會主席，執行董事，提名委員會主席"},{"name":"張韶壬","position":"執行董事"},{"name":"司文","position":"執行董事，薪酬委員會委員"},{"name":"謝東","position":"獨立非執行董事，提名委員會委員，審計委員會主席"},{"name":"高鳳勇","position":"獨立非執行董事，薪酬委員會委員，審計委員會委員"},{"name":"揣姝茵","position":"獨立非執行董事，薪酬委員會主席，提名委員會委員，審計委員會委員"},{"name":"蔡志洋","position":"非執行董事"},{"name":"余濤","position":"非執行董事"}],"executives":[{"name":"朱忠遠","position":"首席執行官"},{"name":"花海清","position":"高級副總裁，藥物發現負責人"},{"name":"於鑫","position":"副總裁，監管事務負責人"},{"name":"曾穎雯","position":"聯席公司秘書"},{"name":"袁佳麗","position":"聯席公司秘書，法律及合規負責人"},{"name":"王昕","position":"首席商務官"},{"name":"邱楊","position":"首席科學官"},{"name":"張韶壬","position":"財務副總裁"},{"name":"司文","position":"人力資源執行總監"},{"name":"顧薇","position":"首席醫學官"},{"name":"施榕","position":"開發科學副總裁"},{"name":"儲瑞銀","position":"轉化醫學副總裁"},{"name":"周嵐","position":"商業戰略副總裁"},{"name":"牟驊","position":"全球首席醫學官"}]}}}